Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Alison Dawn Laws, M.D.

Concepts (80)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms182021191531.560 Why?
Carcinoma, Lobular420214671.480 Why?
Carcinoma, Ductal, Breast5202010851.200 Why?
Mastectomy, Segmental420209171.200 Why?
Neoadjuvant Therapy6202124031.140 Why?
Carcinoma in Situ220218151.080 Why?
Ultrasonography, Mammary320192400.970 Why?
Mastectomy5202016670.810 Why?
Neoplasm, Residual320209320.810 Why?
Diagnostic Services12019390.810 Why?
Sentinel Lymph Node Biopsy320206500.750 Why?
Health Plan Implementation220193650.740 Why?
Mammography5202023540.700 Why?
Lymphatic Metastasis2202130610.580 Why?
Waiting Lists120196610.570 Why?
Carcinoma, Intraductal, Noninfiltrating120208870.490 Why?
Reoperation2201941750.450 Why?
Early Detection of Cancer3202026560.450 Why?
Genetic Testing1202132300.350 Why?
Biopsy1202068490.340 Why?
Guideline Adherence1201823610.330 Why?
Venous Thromboembolism1201814290.320 Why?
Intraoperative Period220185690.310 Why?
Lymph Node Excision3202011720.300 Why?
Models, Statistical1201851040.250 Why?
Axilla220205090.230 Why?
Antineoplastic Combined Chemotherapy Protocols32021111150.230 Why?
Prognosis72021289230.210 Why?
Practice Guidelines as Topic1201876310.200 Why?
Risk Assessment22020237390.200 Why?
Genetic Predisposition to Disease12021170710.180 Why?
Hyperplasia1202111920.180 Why?
Canada2202019050.170 Why?
Antineoplastic Agents12021138980.170 Why?
Chemotherapy, Adjuvant3202134860.160 Why?
Female1720213754590.150 Why?
Frozen Sections120161720.150 Why?
Critical Pathways120194400.150 Why?
Neoplasm Recurrence, Local5202186100.150 Why?
Ambulatory Surgical Procedures120194220.140 Why?
Receptors, Estrogen5202121020.140 Why?
Rural Health Services120183640.140 Why?
Aged, 80 and over62020593310.130 Why?
Neoplasm Invasiveness2201937890.130 Why?
Neoplasm Staging42021112650.130 Why?
Magnetic Resonance Imaging12020331860.120 Why?
Middle Aged1120212164680.120 Why?
Humans1820216866630.120 Why?
Lymph Nodes2202034250.110 Why?
Follow-Up Studies52019397370.110 Why?
Perioperative Care1201910760.100 Why?
Radiotherapy1201816740.100 Why?
Receptors, Progesterone3202011120.100 Why?
Receptor, erbB-24202122120.100 Why?
Retrospective Studies52021673200.100 Why?
Adult820212114000.100 Why?
Combined Modality Therapy2201991140.100 Why?
Aged820201622710.090 Why?
Survival Rate22019136060.080 Why?
Massachusetts1202089200.080 Why?
Hemorrhage1201831490.080 Why?
Prospective Studies22021490710.080 Why?
Reconstructive Surgical Procedures1201820960.070 Why?
Predictive Value of Tests12021154070.070 Why?
Multivariate Analysis12018127340.070 Why?
Quality Improvement1201936490.070 Why?
Health Services Accessibility1201849280.050 Why?
Age Factors12018192950.050 Why?
Young Adult42020560520.050 Why?
Postoperative Complications22019150830.050 Why?
Time Factors12019422710.040 Why?
Geography120187020.040 Why?
Breast1202017350.030 Why?
Risk Factors12018692780.030 Why?
Disease-Free Survival1202171950.020 Why?
Risk1202099150.020 Why?
Patient Discharge1201927540.020 Why?
Gene Expression Profiling1202096610.020 Why?
Treatment Outcome12019609910.010 Why?
Adolescent12019849570.010 Why?
Laws's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (80)
Co-Authors (24)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.